The Women’s Tennis Association (WTA) has announced a new policy requiring female players to undergo a one-time genetic screening for the SRY gene. This decision has sparked mixed reactions within the sports community. Supporters argue that the testing is essential for ensuring fair competition, while critics have labeled the move as “discriminatory and unnecessary,” calling for the WTA to rethink its stance. The policy was revealed last month, marking a significant development in the ongoing discussions about gender and fairness in sports.
The test will clearly help the tennis body understand what the player’s biological sex is. The test can be conducted either through a cheek swab or blood sample. Passing the test will reportedly be mandatory for a player to compete in WTA tournaments. The Sport & Rights Alliance, however, has urged WTA to reconsider the decision. Andrea Florence, executive director of the Sport & Rights Alliance, has claimed that such a move could harm the players.
